Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-06-19
1999-04-06
Cook, Rebecca
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 12, 514171, A61K 3816, A61K 3156
Patent
active
058918442
ABSTRACT:
Novel compositions for the treatment of IRDS and ARDS contain at least one glucocorticosteroid and a pulmonary surfactant. The duration of treatment with these compositions and the mortality associated with these syndromes can be significantly reduced with the administration of these compositions.
REFERENCES:
patent: 4944941 (1990-07-01), Ammann
Medline 93175549, Jobe et al., Am. J. Ostet. Gynecol., 168(2), 508-13 (1993 Feb.).
Medline 93326331, Robertson, Ann. Med., 25(3), 285-8, Ref:23, (1993 Jun.).
Schrod et al., Z. Geburtsh, Perinat., 197, 184-7 (1993).
Possmayer, Am Rev Respir Dis 138:990-998, 1988.
Kwong et al Pediatric Res. 21 (4.2) #1706, 1987.
Kari et al, Pediatrics pp. 730-736, Jan. 5, 1994.
Gladstone et al. J. Applied Physiol. 67(4) pp. 1377-1382, Oct. 1989.
ByK Gulden Lomberg Chemische Fabrik GmbH
Cook Rebecca
LandOfFree
Compositions for treating IRDS and ARDS with a combination of a does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions for treating IRDS and ARDS with a combination of a , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions for treating IRDS and ARDS with a combination of a will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1371396